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Mediterranean spotted fever (MSF) was ﬁ  rst described 
in 1910. Twenty years later, it was recognized as a rickett-
sial disease transmitted by the brown dog tick. In contrast 
to Rocky Mountain spotted fever (RMSF), MSF was thought 
to be a benign disease; however, the ﬁ  rst severe case that 
resulted in death was reported in France in the 1980s. We 
have noted important changes in the epidemiology of MSF 
in the last 10 years, with emergence and reemergence of 
MSF in several countries. Advanced molecular tools have 
allowed Rickettsia conorii conorii to be classiﬁ  ed as a sub-
species of R. conorii. New clinical features, such as multiple 
eschars, have been recently reported. Moreover, MSF has 
become more severe than RMSF; the mortality rate was as 
high as 32% in Portugal in 1997. Whether Rhipicephalus 
sanguineus is the only vector and reservoir for R. conorii 
conorii is a question not yet answered.
M
editerranean spotted fever (MSF) is a tick-borne 
disease caused by Rickettsia conorii. It was ﬁ  rst de-
scribed a century ago as a disease that caused high fever 
and spots (1). Our knowledge about MSF has evolved since 
its ﬁ  rst description. First, we thought that MSF was only 
limited to some regions of the world, i.e., southern Europe, 
North Africa, and India. In fact, an increasing number of 
regions have been reporting MSF cases, such as central Eu-
rope and central and southern Africa. Serologic techniques 
cannot distinguish among different rickettsiae species of the 
spotted group. Consequently, all rickettsioses with spotted 
fever group (SFG) antibodies were considered to have MSF 
in countries where this disease was endemic. Early clinical 
descriptions that relied only on serologic test results were 
likely to include infections related to multiple rickettsial 
species and were probably not describing a unique entity. 
For example, in France, emerging rickettsioses caused by 
bacteria, including R. sibirica mongolitimonae, R. slovaca, 
R. felis, R. helvetica, and R. massiliae, have been recently 
described (1). The ﬁ  rst description of patients with MSF 
in southern France may have included patients with these 
emerging rickettsioses. With new molecular tools such as 
PCR and sequencing, we can now identify much more pre-
cisely the rickettsial agent responsible for the disease.
MSF is an emerging or a reemerging disease in some 
countries. For example, in Oran, Algeria, the ﬁ  rst case of 
MSF was clinically diagnosed in 1993. Since that time, the 
number of cases has steadily increased (2). In some other 
countries of the Mediterranean basin, such as Italy and Por-
tugal, incidence of MSF has substantially increased in the 
past 10 years.
Another point is that MSF was considered for 70 years 
a benign disease when compared with Rocky Mountain 
spotted fever (RMSF). In fact, because of the lack of medi-
cal interest in MSF, its real severity was long ignored. Al-
though the mortality rate was evaluated to be from 1% to 
3% in the early reports in the literature, the ﬁ  rst description 
of a highly severe form of MSF was published in the early 
1980s (3). At present, we know that MSF is at least as se-
vere as RMSF and has a mortality rate as high as 32.3%, 
which occurred in Portugal in 1997 (4).
Although many hypotheses have been suggested, the 
nature and distribution of the reservoir of the rickettsiae in 
nature are still not answered. The aim of this review is to 
show the evolution in our knowledge of MSF in the past 10 
years with an emphasis on epidemiology, clinical features, 
and severe forms.
Historical Background
The historical background of MSF is summarized 
in Table 1. MSF was described in Tunisia by Conor and 
Bruch (1) and was soon reported in other regions around 
the Mediterranean basin. The disease was thereafter also 
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known as boutonneuse fever (spotted fever) because of the 
manifestation of a papular rather than a macular rash. The 
typical inoculation eschar, the tâche noire (black spot), was 
described in 1925 in Marseille by Boinet and Pieri (5). In 
the early 1930s, Durand and Conseil (6) proposed that the 
brown dog tick, Rhipicephalus sanguineus, was the vector 
in Europe after they inoculated humans with crushed ticks. 
Blanc and Caminopetros successfully repeated these exper-
iments on humans and spermophiles (7). Brumpt showed 
that the SFG rickettsia was the causative agent, and in honor 
of Conor, this organism was named R. conorii. Blanc and 
Caminopetros showed that R. conorii could be transmitted 
through transovarial passage (7) in ticks and hypothesized 
that ticks could be the reservoir of R. conorii (Table 1).
Knowledge Gained about MSF 
in the Past 10 Years
New Information about the Agent
R. conorii is an obligate, intracellular, gram-negative 
bacterium (Figures 1, 2). In recent years, the rickettsial 
ﬁ  eld has undergone a substantial evolution, particularly be-
cause of the technologic advances in molecular genetics. 
In the past decade, several rickettsial genomes, including 
that of R. conorii (8), have been sequenced. Availability of 
these genomic data have allowed, in turn, the development 
of global approaches, including proteomics and transcrip-
tomics, powerful tools to gain a better knowledge of cell 
biology and interaction of rickettsiae with their host cells. 
Due to genome sequencing, the taxonomy of rickettsiae has 
undergone extensive reorganization. Until 2005, opinions 
were divided as to whether rickettsial strains related to R. 
conorii belonged to the same species or were distinct spe-
cies. This included Israeli spotted fever rickettsia, Indian 
R. conorii strain (Indian tick typhus rickettsia [ITTR]), and 
Astrakhan spotted fever rickettsia (AFR) (Table 2). In fact, 
phylogenetically, these rickettsiae and R. conorii strain 
Malish (the agent of MSF) constitute a homogeneous clus-
ter supported by signiﬁ  cant bootstrap values and distinct 
from other Rickettsia spp. By estimating the degrees of ge-
notypic variation among isolates of the R. conorii strains 
Malish, ISFR, ITTR, and AFR, Zhu et al. proposed that 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 9, September 2008  1361 
Table 1. Historical reports of MSF* 
Year Discovery  Authors† 
1910 Description of the “fièvre boutonneuse de Tunisie” (7 cases)  Conor and Bruch 
1925 Description of a cluster of MSF (8 cases) in Marseille, France, during the summer  Olmer 
1927 Description of the inoculation eschar, the tache noire (black spot). Description of the disease 
associating fever, spots, and eschar as “Marseille fever” 
Boinet and Pieri 
1930 Experimental transmission of the disease by the brown dog tick  Durand and Conseil 
1932 Demonstration of the transstadial and transovarian transmission of the agent of MSF in ticks. 
Demonstration of Rickettsia in infected ticks 
Blanc and Caminopetros 
1932 Isolation of the Rickettsia causing MSF in the vagina of infected guinea pigs and in infected 
ticks; named R. conorii
Brumpt
1982 First description of cases of malignant MSF  Raoult
*MSF, Mediterranean spotted fever. 
†First or senior authors. 
Table 2. Distribution, vector, and main clinical features of the different subspecies of Rickettsia conorii complex 
Symptoms present, % patients 
Rickettsia Vector tick  Geographic repartition 
Human disease 
name Fever 
Inoculation
eschar Rash
Fatal 
forms? (% 
patients)
R. conorii conorii,
isolates Malish, 
Moroccan
Kenyan
Rhipicephalus
sp.,
Haemaphysalis 
leachii
Mediterranean area 
(southern Europe, northern 
Africa), Croatia, Slovenia, 
Kenya, Somalia, South 
Africa, and surrounding the 
Black Sea (Turkey, 
Bulgaria, Ukraine, 
Romania)
Mediterranean 
spotted fever
91–100 20–87 93–100 Yes  
(0–18.1)
R. conorii 
israelensis
Rh. sanguineus Israel, Portugal, Sicily Israeli spotted 
fever
100 0–46 98–100 Yes  
(0–3.5)
R. conorii caspia Rh.
sanguineus, R. 
pumilio
Astrakhan region, Chad, 
Kosovo
Astrakhan
spotted fever
100 23 94 No
R. conorii indica Rh.
sanguineus,
Boophilus
microplus, H.
leachii
India, Pakistan Indian tick 
typhus
100 Rare 100
(frequently 
purpuric)
NoSYNOPSIS
R. conorii species nomenclature should be modiﬁ  ed through 
the creation of the following subspecies: R. conorii conorii, 
R. conorii caspia, R. conorii israelensis, and R. conorii in-
dica (9). These rickettsiae have discernable serotypes and 
cause diseases with distinct clinical features in deﬁ  ned 
geographic locations, but they are not genetically different 
enough to be considered as new species.
New Information about Epidemiologic Features 
MSF is endemic to the Mediterranean area, including 
northern Africa and southern Europe. Cases are still identi-
ﬁ  ed in new locations within this region. Thus, some cases 
were recently described in Algeria, Malta, Cyprus, Slove-
nia, Croatia, Kenya, Somalia, South Africa, and in areas 
surrounding the Black Sea (Turkey, Bulgaria, and Ukraine). 
Spotted fever cases have been conﬁ  rmed as MSF by the 
use of molecular tools in Portugal, Italy, Malta, Greece, 
Croatia, Spain, France, Turkey, Algeria, Tunisia, Morocco, 
Zimbabwe, Kenya, and South Africa. MSF is suspected to 
be endemic in Slovenia, Albania, Ukraine, Georgia, and 
Zimbabwe, but R. conorii conorii has not been isolated in 
human clinical samples in these countries.
MSF appears to be waxing and waning, as indicated 
by peaks in the number of MSF cases (Figure 3). Incidence 
of the disease sharply increased in the 1980s in Italy (10), 
Spain, and southern France (11). In some countries, MSF is 
reemerging. During the past decade in Portugal, the num-
ber of hospitalizations has increased from <200 to >400 
cases per year (4). In Italy, a notable increase in case num-
bers was reported during the 1990s; cases peaked in 1999 
at 699. In Bulgaria, MSF cases started to sharply decrease 
at the beginning of the 1960s and completely disappeared 
in the 1970s. However, in 1995, a peak of MSF disease 
with 236 cases was noticed in this country and reached 716 
cases in 1997 (12). In Oran, Algeria, the ﬁ  rst case of MSF 
was diagnosed in 1993; since that time, the number of cases 
has steadily increased to reach 134 in 2004 (2). Figure 4 il-
lustrates the distribution and incidence of R. conorii conorii 
infection in countries where MSF is endemic.
Such variations have also been noted for RMSF (13). 
In the United States, the disease is in the midst of its third 
emergence since 1920, after peaking from 1939 to 1949, 
and again from 1974 to 1984 (13,14) (Figure 3). The causes 
of these variations in the incidence of MSF and other SFG 
rickettsioses are unknown. In most countries, no national 
epidemiologic surveillance of MSF cases is conducted. 
Only Italy and Portugal have a formal surveillance pro-
gram. However, in these countries, surveillance is passive 
and not mandatory. Thus, in many countries, reported cases 
depend on the observers and can be affected by such vari-
ables as the need for international publications by physi-
cians. For example, the dramatic increase in MSF cases in 
Oran, Algeria, is mainly due to the renewed interest in the 
disease by 1 physician (2). However, in countries that have 
a surveillance program, incidence of MSF cases actually 
varies in time. Another factor that limits the study of in-
cidence of MSF in European countries is that nonspeciﬁ  c 
serologic tests are used for the diagnosis of MSF and could 
include other SFG rickettsioses. However, in Oran, when 
speciﬁ  c tests are used such as Western blot and molecular 
tools, R. conorii conorii appears to be the main etiologic 
agent of SFG rickettsioses in this area (D. Raoult, unpub. 
data). An increased number of ticks and increased human 
contact with the habitat of infected ticks are possible fac-
tors that would explain variations of incidence. In addition, 
the ecologic changes in the outskirts of large cities during 
the 1980s may have played an important role by moving 
rural sources to suburban zones. Climatic factors could also 
intervene, such as the increase of temperature, the lack of 
rainfall (for example, in Spain [15]), or the reduced number 
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Figure 1. Rickettsia conorii conorii in Vero cells (red rods; 
magniﬁ  cation ×1,000). 
Figure 2. Rickettsia conorii conorii localized in cytoplasm of host 
cells as seen by electron microscopy (magniﬁ  cation ×100,000).Mediterranean Spotted Fever Questions 
of days of frost during the past year in France (16). Climat-
ic variations are suspected to play an important role in tick 
activity and, consequently, on rickettsial prevalence (15). 
It is also conceivable that undetected reservoir–vector sys-
tems have emerged or that the size of the reservoir has in-
creased. This increase in MSF cases in the 1970s could also 
have been caused by a shift in effectiveness of prescribed 
antimicrobial drugs. In fact, before the 1970s, doxycline 
was used as an empiric therapy for patients with a fever of 
unknown origin. Finally, dramatic increases in MSF cases 
during the 1970s may be related to the advent of new di-
agnostic methods, such as microimmunoﬂ  uorescence and 
the increased interest in traveling to several countries such 
as France, Italy, and Spain. Sporadic cases in non–disease-
endemic countries are also observed as a consequence of 
tourism (17).
New Information about Clinical Features 
The clinical description of MSF has not really changed 
since it was ﬁ  rst described. MSF is characterized, just as 
the other rickettsioses, by fever, headaches, and maculo-
papular rash. Most of the studies reporting series of patients 
with MSF could have been affected by many factors. De-
scriptions of the ﬁ  rst clinical cases, which were diagnosed 
on the basis of serologic test results alone, surely included 
infections related to other species of rickettsiae. Clinical 
descriptions with a series of patients are also subject to bi-
ased observations. For example, the eschar (Figure 5) can 
be difﬁ  cult to retrieve and can sometimes be atypical, for 
example, having the aspect of a furuncle, which is difﬁ  cult 
to recognize. This could explain wide variations in the re-
ported presence of an eschar (20%–86%) (4,11).
Eschars are rarely multiple. This observation was, 
however, reported in the early description of the disease by 
Olmer (5). More recently, 2 studies in Sicily found multiple 
eschars in 7 (1.08%) of 645 children (18) and in 6 (1.4%) of 
415 children (19), respectively. In studies in Spain (20,21), 
multiple eschars were found in 3%–11.5% of patients and 
involved more children. These ﬁ  ndings should, however, 
be interpreted with care. The role of R. aeschlimannii cir-
culating in Hyalomma spp. in Spain has to be considered in 
the cases of multiple eschars. Indeed, Rh. sanguineus has 
a low probability of biting humans, and the infection rate 
by rickettsiae is low (<10%). Accordingly, the probability 
of being bitten simultaneously by several infected Rh. san-
guineus is low. Conversely, H. marginatum ticks readily 
bite humans, and persons may receive multiple simultane-
ous tick bites (1). Moreover, in Spain, Fernandez-Soto et al. 
reported R. aeschlimannii in 6 species that frequently feed 
on humans; a total of 4,049 ticks were removed from 3,685 
asymptomatic patients. In this study, R. conorii conorii was 
isolated from only 1 Rh. sanguineus (22). In this context, 
we can hypothesize that cases of spotted fever acquired in 
southern Europe and associated with the presence of sever-
al eschars can be caused by R. aeschlimannii. Nevertheless, 
multiple eschars also exist in MSF. In 2004, our laboratory 
conﬁ  rmed a diagnosis of MSF in 9 patients by using PCR. 
Among them, 3 had multiple eschars, and 2 of the 3 had a 
severe form of MSF (D. Raoult, unpub. data). All of these 
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Figure 3. Fluctuation of incidence of Mediterranean spotted fever 
(MSF) in Italy and Portugal and of Rocky Mounted spotted fever 
(RMSF) in the United States, by year.
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Figure 4. Distribution of the cases of 
Mediterranean spotted fever (MSF) in 
the world and incidence of the disease 
in countries where MSF is endemic.SYNOPSIS
patients were bitten in the southern of France. In Algeria, 
Mouffok et al. reported in a prospective study of 20 of 270 
patients with multiple eschars (D. Raoult, unpub. data).
New Information about the Severity of MSF
Historical Background 
Although mortality rates were determined to be 
1%–3% in the early description, before the antimicrobial 
drug era, MSF was thought to be a benign illness with the 
proportion of deaths <1%. MSF was even named benign 
summer typhus. In comparison, RMSF was described as 
a very severe disease with a mortality rate of 65%–90% in 
western Montana (23). However, a few complications have 
been reported, including renal, neurologic, cardiac, phlebi-
tis, and retinal complications. Severe forms of MSF were 
reported in 1981 (3); 4 of 6 patients with conﬁ  rmed diagno-
ses died. Active surveillance of MSF in Marseille and the 
surrounding area in 1983–1984 found 7 (5%) of 142 pa-
tients with a severe form of MSF. At the same time, severe 
cases of MSF were described in Spain (24). Severe cases of 
MSF were similar to severe cases of RMSF with purpuric 
rash associated with neurologic manifestations and multio-
rgan dysfunction syndrome. At this time, R. conorii conorii 
was the sole agent in cases of spotted fever known in these 
countries. However, we could not exclude the possibility 
that some of these severe cases could be caused by rickett-
siae discovered since this time. In fact, in 1997, in Portugal, 
some of the severe cases were caused by R. conorii israel-
ensis (4). Recently, a severe spotted fever case caused by R. 
australis has been reported (25); the organism was previ-
ously considered to be responsible for a benign disease.
Temporal and Geographic Distribution 
of Severe Cases 
Severity of MSF varies according to the time. For ex-
ample, in 1983, in Salamanca, Spain, MSF was reported as 
a severe disease with complications occurring in 19% of the 
cases (24). During the 2 preceding years, in the same area, 
the annual incidence of complications was 3.7% (1981) and 
4.34% (1982) (24). In 1997 in Beja, a southern Portuguese 
district, the mortality rate in hospitalized patients with MSF 
was 32.3%, the highest obtained there since 1994 (4). The 
mortality rate for the previous years was <15% in this re-
gion. This example illustrates not only a temporal, but also 
a geographic variation in the severity of MSF. Geographic 
variation in severity has also been reported for RMSF. In 
fact, in the United States, the overall case-fatality rate was 
1.4% during 1997–2002 (14); however, in Brazil, the aver-
age case-fatality rate during 1995–2004 was 29.1% (13).
Recent MSF appears to be a more severe disease than 
it was in the past. Mortality rates were 3.2% in Oran, Al-
geria, in 2004 (2); 5.6% in Marseille, France, in 2003 (D. 
Raoult, unpub. data); and 32.3% in hospitalized patients in 
Beja, Portugal, in 1997 (4). This increase in severity has 
not been explained. Indeed, MSF is more quickly recog-
nized and treated with more effective antimicrobial drugs 
than in the past. Thus, we would expect that MSF would be 
less severe. This was the case for RMSF, which had mor-
tality rates in the United States of 2.4% during 1993–1996 
(26) and 1.4% during 1997–2002 (14), in contrast to a mor-
tality rate of 65%–90% at the beginning of the century. The 
ﬁ  rst hypothesis could be that severe forms of MSF were 
not well recognized in the past. In fact, MSF was consid-
ered to be a benign disease before the 1980s (27). MSF 
was not a diagnosis that was evoked when patients were 
hospitalized in intensive care with a febrile rash. Another 
hypothesis is that more virulent strains of R. conorii conorii 
appeared. At present, however, the use of highly variable 
intergenic spacer sequences for multispacer typing of R. 
conorii conorii strains has not led to the identiﬁ  cation of a 
more virulent strain (28). Remarkably, MSF is not a severe 
disease in children. No deaths or severe cases were noticed 
in 60 children in Barcelona during 1979–1980 (29). In Sic-
ily, no severe forms were reported in 645 children during 
1984–1996 (18) or in 415 children during 1997–2004 (19). 
Only 1 report of death (in a 16-year-old patient) was found 
in the literature (30). However, these studies could have 
been affected by recruitment bias. Other risk factors for 
severe MSF, other than advanced age, include the follow-
ing: immunocompromized situations, chronic alcoholism, 
glucose-6-phosphate dehydrogenase deﬁ  ciency, prior pre-
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Figure 5. Typical eschar and spots on the leg of a patient with 
Mediterranean spotted fever.Mediterranean Spotted Fever Questions 
scription of an inappropriate antimicrobial drug, delay in 
treatment (1), and diabetes (4).
Unanswered Questions
Does R. conorii conorii Have Vectors 
Other than Rh. sanguineus?
Rh. sanguineus (Figure 6) is generally accepted as the 
main vector for R. conorii conorii in Europe and North Af-
rica. No other species of ticks have been retrieved from the 
skin of humans infected with R. conorii conorii. Rh. san-
guineus has a weak afﬁ  nity for humans, as evidenced by 
the fact that only 3.5% of larvae, 2% of nymphs, and 5% of 
adults settle on humans when placed in direct contact with 
them (31). However, according to a 2003 report, 22 Rh. 
sanguineus (1 adult and 21 nymphs) were found attached 
to a homeless man with alcoholism, who was living with 
his dog near Marseille (32). Because this infestation was 
associated with the highest summer temperature noted in 
France in the past 50 years, the host-seeking and feeding 
behavior of Rh. sanguineus ticks may have been altered by 
the unusual climatic circumstances. Multiple eschars in-
dicate that the same tick has bitten patients several times 
or that multiple ticks have bitten the patient. In southern 
France, we never noticed multiple eschars until 2004, when 
2 patients had 3 eschars and 1 patient had 2 eschars (D. 
Raoult, unpub. data). Patients with multiple eschars were 
not observed in 2005. Multiple eschars could indicate re-
cent modiﬁ  cation of tick behavior related to unusual cli-
matic circumstances of the previous year. Likewise, labora-
tory evidence has shown an association between changing 
temperature and changing behavior of Rh. sanguineus (D. 
Raoult, unpub. data).
In Africa, vectors other than Rh. sanguineus could 
intervene. PCR, followed by restriction fragment length 
polymorphism, on samples of hemolymph-positive ticks in 
Zimbabwe showed R. conorii conorii to be present in Rh. 
simus and Haemaphysalis leachi (33). In our laboratory, we 
recently isolated R. conorii conorii from H. punctaleachi 
collected in Uganda (D. Raoult, unpub. data).
What Is the Real Reservoir of R. conorii conorii?
Because of transovarial transmission, Rh. sanguineus 
was thought to be the reservoir for R. conorii conorii (7). 
However, this commonly accepted idea is now being 
challenged. In fact, only a small proportion of Rh. san-
guineus ticks are infected with R. conorii conorii; infec-
tion rates are generally <15% (34). Moreover, most Rh. 
sanguineus ticks experimentally infected with R. conorii 
conorii die (35). This increased proportion of deaths in 
Rh. sanguineus has also been shown for naturally infected 
ticks after 1 generation (P. Parola, unpub. data). Curious-
ly, Rh. sanguineus is found throughout the world, but R. 
conorii conorii is found only in some regions of the world. 
Dogs, the usual hosts of Rh. sanguineus, are also found 
everywhere. Even within endemic zones, microfoci exist. 
Early rickettsiologists such as Olmer in southern France 
and Blanc and Caminopetros in Greece have shown that 
foci of MSF are usually small with a low propensity for 
diffusion (7). Clusters in very limited geographic zones 
have also been observed for Rh. sanguineus that transmit 
R. rickettsii infection in Arizona (36). One explanation 
might be that transovarial transmission may occur for a 
limited number of passages and that Rh. sanguineus may 
only be the vector of the disease.
Currently, we do not know the real reservoir for R. 
conorii conorii. Dogs serve as common transport hosts 
by bringing infected ticks closer to their owners. In cer-
tain zones of southern Europe, a correlation between the 
percentage of the canine population with antibodies to R. 
conorii conorii and the incidence of MSF in humans has 
been found (37). Seropositivity was even higher in dogs be-
longing to MSF patients (37). Dogs are transient reservoirs 
because of transient rickettsemia after infection; therefore, 
dogs do not seem to be an efﬁ  cient reservoir for R. conorii 
conorii. Evidence has recently been shown that dogs can 
exhibit febrile illness related to infection with this bacteri-
um (38). In the early description of MSF, Pieri showed that 
rabbits could be bacteremic without severe disease develop-
ing, which suggests that these animals could be a reservoir 
for R. conorii conorii. Le Gac et al. suggested that wild rab-
bits (Oryctolagus cuniculus) could play a role in the trans-
mission of R. conorii conorii on the French Mediterranean 
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Figure 6. Rhipicephalus sanguineus adult tick, the suspected vector 
for Rickettsia conorii conorii.SYNOPSIS
coast because a large drop in MSF cases occurred in 1952 
during an outbreak of myxomatosis, which killed all the 
wild rabbits on the French Mediterranean coast. MSF reap-
peared in 1967 with the reappearance of wild rabbits (39). 
Ruiz Beltran et al. (40) found that 76.5% of wild rabbits 
and 25% of hares had antibodies to R. conorii conorii in 
Salamanca, Spain. Hedgehogs and other small rodents are 
also candidates for the reservoir because antibodies against 
rickettsiae have been detected in serum of these animals 
(39). Because R. conorii conorii has never been isolated in 
the Americas, its reservoir is most likely a mammal present 
only in the Old World that has yet to be determined.
Conclusion
Our knowledge regarding MSF has undergone notable 
changes within the past 10 years. Molecular tools have al-
lowed us to better discriminate rickettsial species and sub-
species of the SFG. We now know that >1 rickettsiosis can 
be present in the same country. Patients who have been 
included in series of MSF cases may have had other rick-
ettsioses. Moreover, MSF has a wider distribution than pre-
viously described. The disease has emerged and reemerged 
in several countries in the Mediterranean basin. New clini-
cal features, such as multiple eschars, previously suggest-
ed in the early description, have now been conﬁ  rmed in 
MSF. MSF is becoming an increasingly severe disease with 
death rates ranging from 3.2% to 32%. However, questions 
persist regarding the vector and reservoir for this disease, 
which need to be addressed.
Dr Rovery is a specialist in infectious diseases in Marseille, 
France. His research interests are focused on rickettsial diseases, 
particularly R. conorii infection.
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